A phase II trial of interleukin-2 in myelodysplastic syndromes.

Nand S, Stock W, Stiff P, Sosman J, Martone B, Radvany R
Br J Haematol. 1998 101 (1): 205-7

PMID: 9576203 · DOI:10.1046/j.1365-2141.1998.00672.x

MeSH Terms (13)

Adult Aged Aged, 80 and over CD56 Antigen Female Humans Interleukin-2 Killer Cells, Natural Lymphocyte Count Male Middle Aged Myelodysplastic Syndromes Receptors, IgG

Connections (1)

This publication is referenced by other Labnodes entities: